[1]
2025. Serum ferritin as a prognostic biomarker in CAR-T therapy for multiple myeloma: A meta-analysis. Biomolecules and Biomedicine. 25, 11 (Mar. 2025), 2416–2427. DOI:https://doi.org/10.17305/bb.2025.12129.